[1]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534-537.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(4):534-537.
点击复制

经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年4期
页码:
534-537
栏目:
针灸经络
出版日期:
2020-04-05

文章信息/Info

Title:
Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD
文章编号:
DOI:10.3969/j.issn.10007369.2020.04.040
作者:
杜沂岚; 唐 敏; 陈朝晖△; 朱海燕
成都医学院第一附属医院中西医结合科(成都 610500)
Author(s):
DU Yilan; TANG Min; CHEN Zhaohui; et al.
Department of Integrated Traditional Chinese and Western Medicine,The First Affiliated Hospital of Chengdu Medical College(Chengdu 610500)
关键词:
慢性阻塞性肺疾病;  急性加重期;  中药离子导入;  振动排痰;  肺俞;  肾俞
Keywords:
Chronic obstructive pulmonary disease;  Acute exacerbation;  Chinese medicine iontophoresis;  Vibration sputum discarding;  Feishu;  Shenshu
分类号:
R563.9
文献标志码:
A
摘要:
目的:探讨经肺腧穴中药离子导入联合振动排痰干预慢性阻塞性肺疾病急性加重期(AECOPD)的临床疗效。方法:将62例AECOPD患者随机分为对照组和观察组,每组31例,对照组给予振动排痰干预,观察组基于以上加予经肺腧穴中药离子导入干预,观察两组干预前及干预14 d后的中医症状体征积分,评估两组临床疗效,对比两组干预前及干预14 d后的临床观察指标和生活质量。结果:干预后,两组喘息、咳嗽、咯痰及湿罗音评分显著降低(P<0.05),观察组显著高于对照组(P<0.05); 观察组总有效率显著高于对照组(96.77%与80.65%,P<0.05); 干预后,两组动脉血氧分压(PaO2)值显著提高(P<0.05),日排痰量显著增加(P<0.05),呼吸困难指数Borg(Borg Scale)量表显著下降(P<0.05),观察组变化幅度显著大于对照组(P<0.05),观察组住院时间显著短于对照组(P<0.05); 干预后,两组简化St George's呼吸问卷(SGRQ)量表关于症状、活动、疾病影响3个维度评分及总分显著降低(P<0.05),观察组变化幅度显著大于对照组(P<0.05)。结论:经肺腧穴中药离子导入联合振动排痰干预AECOPD患者疗效确切,可有效改善其症状体征、肺部血氧供应和气道呼吸困难,有助于提高其生活质量。
Abstract:
Objective:To explore the clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:62 patients with AECOPD were randomly divided into control group and observation group,with 31 cases in each group.Control group was given vibration sputum discarding intervention,and observation group was given Chinese medicine iontophoresis via Feishu point based on the above intervention.The scores of TCM symptoms and signs were observed in the two groups before intervention and after 14 d of intervention.The clinical efficacy of the two groups was evaluated.The clinical observation indicators and quality of life were compared between the two groups before intervention and after 14 d of intervention.Results:After intervention,the scores of wheezing,cough,expectoration and wet rales in the two groups were significantly decreased(P<0.05),and the scores in observation group were significantly higher than those in control group(P<0.05).The total effective rate in observation group was significantly higher than that in control group(96.77% vs 80.65%)(P<0.05).After intervention,the arterial partial pressure of oxygen(PaO2)was significantly increased(P<0.05),and the daily sputum excretion volume was significantly increased(P<0.05),and the dyspnea index Borg(Borg Scale)score was significantly decreased(P<0.05),and the changes in observation group were significantly greater than those in control group(P<0.05),and the hospital stay in observation group was significantly shorter than that in control group(P<0.05).After intervention,the scores of three dimensions of symptoms,activities and disease influence and the total score of simplified St George' s Respiratory Questionnaire(SGRQ)scale were significantly reduced in the two groups(P<0.05),and the changes in observation group were significantly greater than those in control group(P<0.05).Conclusion:Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding has exact efficacy in the treatment of AECOPD,and it can effectively improve the symptoms and signs,lung blood oxygen supply and airway dyspnea,and help to improve quality of life.

参考文献/References:

[1] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J].国际呼吸杂志,2017,37(14):1041-1057.
[2] 柴春艳,刘娅萍,王 甜,等.乌司他丁辅助治疗70岁以上慢性阻塞性肺病急性加重期49例疗效及其对患者炎性因子影响研究[J].陕西医学杂志,2018,47(6):790-792.
[3] 高丽云,盛海燕,朱永磊.机械辅助排痰联合穴位按摩在痰浊壅肺型慢性阻塞性肺疾病病人护理中的应用[J].护理研究,2017,31(2):182-185.
[4] 朱燕生,胡马洪,季春莲.白芥子穴位贴敷联合机械振动对慢性阻塞性肺疾病机械通气患者排痰作用观察[J].浙江中医杂志,2019,54(3):208.
[5] 陈 麒,田 君,蒋 骏.改良中医呼吸导引康复技术治疗慢性阻塞性肺疾病稳定期患者的临床观察[J].上海中医药大学学报,2017,31(3):33-39.
[6] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸病杂志,2013,36(4):255-264.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:3-4.
[8] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:61-65.
[9] Medinas AM.Quality of life in patients with chronic obstructive pulmonary diseasa:the predictive validity of the BOSE index[J].Chron Respir Dis,2008,5(1):7-11.
[10] Jone PW,Quirk FH,Baveystock CM,et al.The St.George's respiratory questionnaire[J].Respir Med,1991,85(1):25-31.
[11] 王梁敏,焦蕴岚,綦文婧,等.中药离子导入法治疗肺阳气虚背冷症30例临床观察[J].北京中医药,2018,37(4):343-345.
[12] 余晓芬,陈 进,陈新伟.经肺俞穴超声导入阿奇霉素治疗小儿支原体感染的安全性及临床疗效[J].中国地方病防治杂志,2017,323(1):83-87.
[13] 王 琼,刘志敏,段培蓓,等.局部取穴振动排痰对慢性阻塞性肺疾病急性期排痰效果观察[J].护理研究,2016,30(23):2900-2902.
[14] 陈 聪,张 伟.从中医角度浅述慢性阻塞性肺疾病合并代谢综合征[J].陕西中医,2016,37(5):607-608.
[15] 姜 昕,唐敏婕,杜闻媛.穴位贴敷联合中药离子导入法对慢性阻塞性肺疾病患者生活质量的影响[J].中草药,2016,47(7):1176-1179.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(4):610.
[3]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(4):995.
[4]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(4):1491.
[5]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(4):57.
[6]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(4):180.
[7]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[8]任素霞,陶赟臻△,张美玲.益气消癥通络方联合西药对慢性阻塞性肺疾病急性加重期患者BODE指数及CRP的影响[J].陕西中医,2020,(7):920.[doi:DOI:10.3969/j.issn.10007369.2020.07.024]
[9]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
　TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(4):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
[10]蔡东林,孙钟和,赵益庆.慢性阻塞性肺疾病稳定期BODE指数、IL-8、TNF-α水平与肺肾气虚证相关性研究*[J].陕西中医,2020,(11):1573.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.015]
[11]杨 诚.清肺化痰汤合桑白皮汤治疗慢性阻塞性肺疾病急性加重期痰热壅肺证疗效及对患者免疫功能的影响[J].陕西中医,2021,(9):1223.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.018]
[12]刘敬敬,程玉峰,崔 磊.化痰止咳平喘汤联合布地奈德治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2024,(2):204.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.012]
　LIU Jingjing,CHENG Yufeng,CUI Lei.Huatan Zhike Pingchuan decoction combined with budesonide in the treatment of acute exacerbation of COPD[J].,2024,(4):204.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.012]

备注/Memo

备注/Memo:
*四川省中医药管理局科研项目(2018QN051)
更新日期/Last Update: 2020-04-13